Why the study?
Stiffness from arthrofibrosis after total knee arthroplasty is challenging, and it was unknown whether ACEIs or ARBs, which prevent fibrotic disorders in other organs, reduce postoperative arthrofibrosis.
Does the use of ACEIs or ARBs improve postoperative range of motion and reduce the incidence of arthrofibrosis in patients undergoing total knee arthroplasty?
Does the use of ACEIs or ARBs improve postoperative range of motion and reduce the incidence of arthrofibrosis in patients undergoing total knee arthroplasty?
Standard oral doses of ACE inhibitors or ARBs do not improve postoperative range of motion or prevent arthrofibrosis following total knee arthroplasty.
Answers are grounded in this paper and cite their sources.
ACEI/ARB use shows no association with improved ROM after TKA; leaves open effects on arthrofibrosis in prospective trials.
Background Stiffness and pain from arthrofibrosis following total knee arthroplasty (TKA) is a challenging problem, and investigating methods to prevent or reduce the incidence of postoperative arthrofibrosis is critical. Studies have shown that angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are efficacious at preventing fibrotic disorders in the lungs, liver, kidneys, and eyes. Our aim was to determine if ACEI or ARB use postoperatively reduces the incidence of arthrofibrosis in TKA patients. Methods In a retrospective review, we analyzed 141 consecutive TKAs performed at a single institution by a single surgeon from December 2010 to December 2014. Range of motion (ROM) in patients already taking ACEI, ARB, or neither medication was compared. Independent variables recorded were gender, age, BMI, presence of diabetes or preoperative opioid or statin use, preoperative ROM, and use of ACEIs or ARBs. Dependent variables recorded were postoperative knee flexion, extension, and total arc of motion. The primary outcome variable was success or failure of achieving 118o total arc of motion postoperatively, based on a study that found significant compromise of function in TKA patients who failed to obtain this goal. Secondary endpoints were postoperative knee flexion, extension, and total arc of motion. Results The use of neither ACEIs nor ARBs showed a significant difference in attaining greater than 118° of motion postoperatively compared to controls at 6 months. Significant predictors of obtaining > 118° motion were BMI (p < 0.05), preoperative flexion (p < 0.001), and preoperative total arc of motion (p < 0.002). Significant predictors of secondary ROM outcomes were preoperative ROM and BMI. Conclusions Our study demonstrated that the principle predictor of postoperative ROM is BMI and preoperative ROM. The use of ACEIs or ARBs did not result in a greater likelihood of obtaining satisfactory ROM postoperatively.
No takes yet. Share an insight, caveat, or question.
Langston et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: